Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Choosing zero based budgeting means every dollar has a purpose, reducing waste and improving long-term planning compared with traditional budgets.
24,527 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A new Ipsos poll reveals growing World Cup enthusiasm among U.S. fans while broad adoption lags. The findings hint at...
Rate expands its mortgage team by bringing 14 loan officers from New American Funding, aiming to boost production and...
Stocks hover near record highs as earnings show resilience, but analysts warn that the gap between prices and profits...
As market volatility lingers in 2026, the timing of Social Security claims tied to birthdays can dramatically alter m...
A bold take on Tesla's future: could the Optimus robot redefine the company and its stock by 2026? This article lays ...
As TJX prepares for the (tjx) 2026 earnings call, investors should focus on sales trends, inventory discipline, and o...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
As 2025 unfolds, sight sciences (sght) 2025 becomes a focal point for ophthalmology investors. This guide breaks down...
BNO has jumped about 52% year-to-date, yet roll costs and futures contango are quietly eroding its gains. Here's what...
Two popular 3x ETFs chase daily moves in different corners of the market. This guide breaks down when levered bets on...
FRP Holdings delivered a resilient Q3 2024 performance across its diversified subsidiaries. This deep dive reviews th...